30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Nurix Therapeutics Inc (NRIX)

Track

Over the last 90 days, Nurix Therapeutics Inc. has seen significant insider selling, with a net value of -$146,744.96. Executives were the primary sellers, with a net count of -3. Notable transactions include multiple planned and proposed sales by Christine Ring (Chief Legal Officer) and Hans van Houte (Chief Financial Officer). The stock has seen an 18.6% price increase over the same period.
Stock chart
Ticker: NRIX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Hansen Gwenn
Chief Scientific Officer
1 sale — total 100,000 USD
Planned sale 25 Jun 2026
Value US$377,569.16 | Price 69.14 | Shares 53,642
Planned sale 25 Jun 2026
Value US$378,177.45 | Price 98.84 | Shares 21,629
Proposed sale 25 Jun 2026
Value US$100,000.00 | Price 19.30 | Shares 1,000
Proposed sale 25 Jun 2026
Value US$100,000.00 | Price 19.30 | Shares 1,000
Planned sale 2 Jun 2026
Value US$135,252.73 | Price 16.60 | Shares 8,148
Proposed sale 2 Jun 2026
Value US$141,693.72 | Price 17.39 | Shares 8,148
Planned sale 5 May 2026
Value US$9,995.91 | Price 17.18 | Shares 582
Planned sale 5 May 2026
Value US$223,323.06 | Price 16.58 | Shares 13,473
Proposed sale 5 May 2026
Value US$237,951.15 | Price 16.93 | Shares 14,055
Planned sale 4 May 2026
Value US$138,209.64 | Price 16.96 | Shares 8,148
Proposed sale 4 May 2026
Value US$136,967.88 | Price 16.81 | Shares 8,148
Planned sale 1 May 2026
Value US$90,406.68 | Price 16.76 | Shares 5,394
Proposed sale 1 May 2026
Value US$90,079.80 | Price 16.70 | Shares 5,394
Sale 30 Apr 2026
Value US$39,748.98 | Price 16.65 | Shares 2,388
Sale 30 Apr 2026
Value US$53,497.99 | Price 16.65 | Shares 3,214
Sale 30 Apr 2026
Value US$53,497.99 | Price 16.65 | Shares 3,214
Planned sale 2 Apr 2026
Value US$124,148.63 | Price 15.24 | Shares 8,148
Proposed sale 2 Apr 2026
Value US$126,131.04 | Price 15.48 | Shares 8,148
Planned sale 2 Mar 2026
Value US$125,792.90 | Price 15.44 | Shares 8,148
Proposed sale 2 Mar 2026
Value US$130,123.56 | Price 15.97 | Shares 8,148
Planned sale 9 Feb 2026
Value US$237,618.21 | Price 16.66 | Shares 14,261
Proposed sale 9 Feb 2026
Value US$240,297.85 | Price 16.85 | Shares 14,261
Sale 30 Jan 2026
Value US$1,268.13 | Price 17.37 | Shares 73
Sale 30 Jan 2026
Value US$59,498.37 | Price 16.58 | Shares 3,588
Sale 30 Jan 2026
Value US$1,702.43 | Price 17.37 | Shares 98
Sale 30 Jan 2026
Value US$79,546.73 | Price 16.58 | Shares 4,797
Sale 30 Jan 2026
Value US$1,528.71 | Price 17.37 | Shares 88
Sale 30 Jan 2026
Value US$71,852.41 | Price 16.58 | Shares 4,333
Planned sale 20 Jan 2026
Value US$69,273.11 | Price 18.42 | Shares 3,760
Proposed sale 18 Dec 2025
Value US$136,939.20 | Price 18.21 | Shares 7,520
Planned sale 18 Dec 2025
Value US$3,711.00 | Price 18.56 | Shares 200
Planned sale 18 Dec 2025
Value US$63,603.32 | Price 17.87 | Shares 3,560
Proposed sale 24 Nov 2025
Value US$630,176.00 | Price 16.76 | Shares 37,600
Planned sale 24 Nov 2025
Value US$641,696.64 | Price 17.07 | Shares 37,600
Proposed sale 3 Nov 2025
Value US$81,314.96 | Price 12.94 | Shares 6,284
Planned sale 3 Nov 2025
Value US$78,931.44 | Price 12.56 | Shares 6,284
Sale 30 Oct 2025
Value US$40,053.67 | Price 12.80 | Shares 3,130
Sale 30 Oct 2025
Value US$52,300.11 | Price 12.80 | Shares 4,087
Sale 30 Oct 2025
Value US$46,631.17 | Price 12.80 | Shares 3,644
Proposed sale 1 Aug 2025
Value US$60,826.52 | Price 11.26 | Shares 5,402
Planned sale 1 Aug 2025
Value US$59,597.56 | Price 11.03 | Shares 5,402
Sale 30 Jul 2025
Value US$51,695.34 | Price 12.01 | Shares 4,304
Sale 30 Jul 2025
Value US$46,134.25 | Price 12.01 | Shares 3,841
Sale 30 Jul 2025
Value US$51,743.39 | Price 12.01 | Shares 4,308
Proposed sale 2 May 2025
Value US$69,169.68 | Price 11.16 | Shares 6,198
Planned sale 2 May 2025
Value US$70,242.55 | Price 11.33 | Shares 6,198
Sale 30 Apr 2025
Value US$38,841.24 | Price 11.50 | Shares 3,377
Sale 30 Apr 2025
Value US$28,041.14 | Price 11.50 | Shares 2,438
Sale 30 Apr 2025
Value US$33,285.92 | Price 11.50 | Shares 2,894
Proposed sale 3 Mar 2025
Value US$89,996.25 | Price 15.45 | Shares 5,825
Planned sale 3 Mar 2025
Value US$10,590.79 | Price 15.13 | Shares 700
Planned sale 3 Mar 2025
Value US$73,796.92 | Price 14.40 | Shares 5,125
Planned sale 31 Jan 2025
Value US$2,048.00 | Price 20.48 | Shares 100
Planned sale 31 Jan 2025
Value US$112,885.87 | Price 19.94 | Shares 5,660
Proposed sale 31 Jan 2025
Value US$115,286.40 | Price 20.02 | Shares 5,760
Sale 30 Jan 2025
Value US$5,914.75 | Price 20.33 | Shares 291
Sale 30 Jan 2025
Value US$58,014.12 | Price 19.81 | Shares 2,929
Sale 30 Jan 2025
Value US$5,162.70 | Price 20.33 | Shares 254
Sale 30 Jan 2025
Value US$50,645.99 | Price 19.81 | Shares 2,557
Sale 30 Jan 2025
Value US$6,768.42 | Price 20.33 | Shares 333
Sale 30 Jan 2025
Value US$66,491.43 | Price 19.81 | Shares 3,357
Proposed sale 2 Jan 2025
Value US$108,518.40 | Price 18.84 | Shares 5,760
Planned sale 2 Jan 2025
Value US$112,294.66 | Price 19.50 | Shares 5,760
Proposed sale 2 Dec 2024
Value US$127,353.60 | Price 22.11 | Shares 5,760
Planned sale 2 Dec 2024
Value US$125,155.01 | Price 21.73 | Shares 5,760
Proposed sale 4 Nov 2024
Value US$80,506.30 | Price 24.47 | Shares 3,290
Planned sale 4 Nov 2024
Value US$82,250.00 | Price 25.00 | Shares 3,290
Proposed sale 1 Nov 2024
Value US$87,160.68 | Price 24.58 | Shares 3,546
Proposed sale 1 Nov 2024
Value US$141,580.80 | Price 24.58 | Shares 5,760
Planned sale 1 Nov 2024
Value US$139,866.62 | Price 24.28 | Shares 5,760
Planned sale 1 Nov 2024
Value US$86,083.41 | Price 24.28 | Shares 3,546
Sale 30 Oct 2024
Value US$101,643.51 | Price 24.31 | Shares 4,182
Sale 30 Oct 2024
Value US$83,536.28 | Price 24.31 | Shares 3,437
Sale 30 Oct 2024
Value US$57,554.24 | Price 24.31 | Shares 2,368
Planned sale 14 Oct 2024
Value US$82,250.00 | Price 25.00 | Shares 3,290
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-25 2026-06-25 PlS Planned sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
53,642 +10.2%
69.14
US$377,569 		53,642 +10.2% 69.14 US$377,569
2026-06-25 2026-06-25 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
21,629 -3.5%
98.84
US$378,177 		21,629 -3.5% 98.84 US$378,177
2026-06-25 2026-06-25 PrS Proposed sale
3.1
GWENN M HANSEN

Officer

Officer
522
286.44
US$1,425,932 		522 286.44 US$1,425,932
2026-06-25 2026-06-25 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
1,000
19.30
US$100,000 		1,000 19.30 US$100,000
2026-06-02 2026-06-02 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
8,148 -37.5%
16.60
US$135,253 		8,148 -37.5% 16.60 US$135,253
2026-06-02 2026-06-02 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
8,148
17.39
US$141,694 		8,148 17.39 US$141,694
2026-05-05 2026-05-05 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
582 -1.5%
17.18
US$9,996 		582 -1.5% 17.18 US$9,996
2026-05-05 2026-05-05 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
13,473 -26.1%
16.58
US$223,323 		13,473 -26.1% 16.58 US$223,323
2026-05-05 2026-05-05 PrS Proposed sale
3.1
JOHANNES VAN HOUTE

Officer

Officer
14,055
16.93
US$237,951 		14,055 16.93 US$237,951
2026-05-04 2026-05-04 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
8,148 -30.8%
16.96
US$138,210 		8,148 -30.8% 16.96 US$138,210
2026-05-04 2026-05-04 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
8,148
16.81
US$136,968 		8,148 16.81 US$136,968
2026-05-01 2026-05-01 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
5,394 -16.9%
16.76
US$90,407 		5,394 -16.9% 16.76 US$90,407
2026-05-01 2026-05-01 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
5,394
16.70
US$90,080 		5,394 16.70 US$90,080
2026-04-30 2026-04-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
2,388 -4.4%
16.65
US$39,749 		2,388 -4.4% 16.65 US$39,749
2026-04-30 2026-04-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
3,214 -2.6%
16.65
US$53,498 		3,214 -2.6% 16.65 US$53,498
2026-04-30 2026-04-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
3,214 -9.2%
16.65
US$53,498 		3,214 -9.2% 16.65 US$53,498
2026-04-02 2026-04-02 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
8,148 -23.5%
15.24
US$124,149 		8,148 -23.5% 15.24 US$124,149
2026-04-02 2026-04-02 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
8,148
15.48
US$126,131 		8,148 15.48 US$126,131
2026-03-02 2026-03-02 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
8,148 -19.1%
15.44
US$125,793 		8,148 -19.1% 15.44 US$125,793
2026-03-02 2026-03-02 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
8,148
15.97
US$130,124 		8,148 15.97 US$130,124
2026-02-09 2026-02-09 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
14,261 -25.0%
16.66
US$237,618 		14,261 -25.0% 16.66 US$237,618
2026-02-09 2026-02-09 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
14,261
16.85
US$240,298 		14,261 16.85 US$240,298
2026-01-30 2026-01-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
73 -0.2%
17.37
US$1,268 		73 -0.2% 17.37 US$1,268
2026-01-30 2026-01-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
3,588 -7.3%
16.58
US$59,498 		3,588 -7.3% 16.58 US$59,498
2026-01-30 2026-01-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
98 -0.1%
17.37
US$1,702 		98 -0.1% 17.37 US$1,702
2026-01-30 2026-01-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
4,797 -5.4%
16.58
US$79,547 		4,797 -5.4% 16.58 US$79,547
2026-01-30 2026-01-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
88 -0.2%
17.37
US$1,529 		88 -0.2% 17.37 US$1,529
2026-01-30 2026-01-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
4,333 -7.1%
16.58
US$71,852 		4,333 -7.1% 16.58 US$71,852
2026-01-20 2026-01-20 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
3,760 -6.9%
18.42
US$69,273 		3,760 -6.9% 18.42 US$69,273
2025-12-18 2025-12-18 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
7,520
18.21
US$136,939 		7,520 18.21 US$136,939
2025-12-18 2025-12-18 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
200 -0.4%
18.56
US$3,711 		200 -0.4% 18.56 US$3,711
2025-12-18 2025-12-18 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
3,560 -6.5%
17.87
US$63,603 		3,560 -6.5% 17.87 US$63,603
2025-11-24 2025-11-24 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
37,600
16.76
US$630,176 		37,600 16.76 US$630,176
2025-11-24 2025-11-24 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
37,600 -42.5%
17.07
US$641,697 		37,600 -42.5% 17.07 US$641,697
2025-11-03 2025-11-03 PrS Proposed sale
3.1
JOHANNES VAN HOUTE

Officer

Officer
6,284
12.94
US$81,315 		6,284 12.94 US$81,315
2025-11-03 2025-11-03 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
6,284 -14.3%
12.56
US$78,931 		6,284 -14.3% 12.56 US$78,931
2025-10-30 2025-10-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
3,130 -6.7%
12.80
US$40,054 		3,130 -6.7% 12.80 US$40,054
2025-10-30 2025-10-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
4,087 -5.1%
12.80
US$52,300 		4,087 -5.1% 12.80 US$52,300
2025-10-30 2025-10-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
3,644 -6.7%
12.80
US$46,631 		3,644 -6.7% 12.80 US$46,631
2025-08-01 2025-08-01 PrS Proposed sale
3.1
JOHANNES VAN HOUTE

Officer

Officer
5,402
11.26
US$60,827 		5,402 11.26 US$60,827
2025-08-01 2025-08-01 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
5,402 -13.2%
11.03
US$59,598 		5,402 -13.2% 11.03 US$59,598
2025-07-30 2025-07-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
4,304 -9.5%
12.01
US$51,695 		4,304 -9.5% 12.01 US$51,695
2025-07-30 2025-07-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
3,841 -8.0%
12.01
US$46,134 		3,841 -8.0% 12.01 US$46,134
2025-07-30 2025-07-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
4,308 -5.9%
12.01
US$51,743 		4,308 -5.9% 12.01 US$51,743
2025-05-02 2025-05-02 PrS Proposed sale
3.1
JOHANNES VAN HOUTE

Officer

Officer
6,198
11.16
US$69,170 		6,198 11.16 US$69,170
2025-05-02 2025-05-02 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
6,198 -15.5%
11.33
US$70,243 		6,198 -15.5% 11.33 US$70,243
2025-04-30 2025-04-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
3,377 -5.2%
11.50
US$38,841 		3,377 -5.2% 11.50 US$38,841
2025-04-30 2025-04-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
2,438 -5.8%
11.50
US$28,041 		2,438 -5.8% 11.50 US$28,041
2025-04-30 2025-04-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
2,894 -7.2%
11.50
US$33,286 		2,894 -7.2% 11.50 US$33,286
2025-03-03 2025-03-03 PrS Proposed sale
3.1
JOHANNES VAN HOUTE

Officer

Officer
5,825
15.45
US$89,996 		5,825 15.45 US$89,996
2025-03-03 2025-03-03 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
700 -2.0%
15.13
US$10,591 		700 -2.0% 15.13 US$10,591
2025-03-03 2025-03-03 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
5,125 -13.0%
14.40
US$73,797 		5,125 -13.0% 14.40 US$73,797
2025-02-03 2025-01-31 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
100 -0.3%
20.48
US$2,048 		100 -0.3% 20.48 US$2,048
2025-02-03 2025-01-31 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
5,660 -14.8%
19.94
US$112,886 		5,660 -14.8% 19.94 US$112,886
2025-01-31 2025-01-31 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
5,760
20.02
US$115,286 		5,760 20.02 US$115,286
2025-01-30 2025-01-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
291 -0.9%
20.33
US$5,915 		291 -0.9% 20.33 US$5,915
2025-01-30 2025-01-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
2,929 -8.2%
19.81
US$58,014 		2,929 -8.2% 19.81 US$58,014
2025-01-30 2025-01-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
254 -0.6%
20.33
US$5,163 		254 -0.6% 20.33 US$5,163
2025-01-30 2025-01-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
2,557 -6.0%
19.81
US$50,646 		2,557 -6.0% 19.81 US$50,646
2025-01-30 2025-01-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
333 -0.6%
20.33
US$6,768 		333 -0.6% 20.33 US$6,768
2025-01-30 2025-01-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
3,357 -5.6%
19.81
US$66,491 		3,357 -5.6% 19.81 US$66,491
2025-01-02 2025-01-02 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
5,760
18.84
US$108,518 		5,760 18.84 US$108,518
2025-01-02 2025-01-02 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
5,760 -17.0%
19.50
US$112,295 		5,760 -17.0% 19.50 US$112,295
2024-12-02 2024-12-02 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
5,760
22.11
US$127,354 		5,760 22.11 US$127,354
2024-12-02 2024-12-02 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
5,760 -17.0%
21.73
US$125,155 		5,760 -17.0% 21.73 US$125,155
2024-11-04 2024-11-04 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
3,290
24.47
US$80,506 		3,290 24.47 US$80,506
2024-11-04 2024-11-04 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
3,290 -10.5%
25.00
US$82,250 		3,290 -10.5% 25.00 US$82,250
2024-11-01 2024-11-01 PrS Proposed sale
3.1
JOHANNES VAN HOUTE

Officer

Officer
3,546
24.58
US$87,161 		3,546 24.58 US$87,161
2024-11-01 2024-11-01 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
5,760
24.58
US$141,581 		5,760 24.58 US$141,581
2024-11-01 2024-11-01 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
5,760 -17.0%
24.28
US$139,867 		5,760 -17.0% 24.28 US$139,867
2024-11-01 2024-11-01 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
3,546 -9.5%
24.28
US$86,083 		3,546 -9.5% 24.28 US$86,083
2024-10-30 2024-10-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
4,182 -13.0%
24.31
US$101,644 		4,182 -13.0% 24.31 US$101,644
2024-10-30 2024-10-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
3,437 -6.4%
24.31
US$83,536 		3,437 -6.4% 24.31 US$83,536
2024-10-30 2024-10-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
2,368 -6.0%
24.31
US$57,554 		2,368 -6.0% 24.31 US$57,554
2024-10-15 2024-10-14 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
3,290 -11.8%
25.00
US$82,250 		3,290 -11.8% 25.00 US$82,250
Explore more

More insider trading research around Nurix Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America